TrialsgrambetaRCTs are beautiful

ZEUS

2011

Everolimus Conversion in Kidney Transplant Recipients

In 300 kidney-transplant recipients, early conversion from ciclosporin to everolimus improved kidney function compared with continued ciclosporin.

Result

Primary endpoint: eGFR at 12 months

71.8 vs 61.9 mL/min; +9.8 (p<0.0001); more biopsy-proven rejection with everolimus (10% vs 3%).

Original publication
Subtopic
mTOR inhibitors
Design
Open-label RCT
Relevance
Supporting: context rather than must-know.
Source
Budde K, et al. Lancet. 2011;377(9768):837-847.doi 10.1016/S0140-6736(10)62318-5

Discussion & critique

Showed mTOR conversion improves function at the cost of more rejection; the benefit was sustained at 5 years.